α-Lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis

Journal of Neuroimmunology

Volumn 148, Issue 1-2, 2004, Pages 146-153

  Morini, Monica ^a   Roccatagliata, Luca ^b   Dell'Eva, Raffaella ^a   Pedemonte, Enrico ^b   Furlan, Roberto ^c   Minghelli, Simona ^a   Giunti, Debora ^b   Pfeffer, Ulrich ^a   Marchese, Monica ^b   Noonan, Douglas ^a   Mancardi, Gianluigi ^b,d   Albini, Adriana ^a   Uccelli, Antonio ^b,d  

^a UNIVERSITY OF GENOA   (Italy)

^b Neuroimmunology Unit   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

Author keywords

Anti oxidant; Experimental autoimmune encephalomyelitis; Inflammation; Invasion; Multiple sclerosis

Indexed keywords

ANTIOXIDANT; GAMMA INTERFERON; INTERLEUKIN 4; NEUROPROTECTIVE AGENT; THIOCTIC ACID;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN PROTECTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEMYELINATION; DOWN REGULATION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; FEMALE; IMMUNIZATION; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY INFILTRATE; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MOUSE; MULTIPLE SCLEROSIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

EID: 10744226446     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2003.11.021     Document Type: Article

References (23)

1. Bogdan C. Nitric oxide and the immune response. Nat. Immunol. 2:2001;907-916.
2. Goetzl E.J., Banda M.J., Leppert D. Matrix metalloproteinases in immunity. J. Immunol. 156:1996;1-4.
3. Kieseier B.C., Seifert T., Giovannoni G., Hartung H.P. Matrix metalloproteinases in inflammatory demyelination: targets for treatment. Neurology. 53:1999;20-25.
4. Kolb H., Kolb-Bachofen V. Nitric oxide in autoimmune disease: cytotoxic or regulatory mediator? Immunol. Today. 19:1998;556-561.
5. Liedtke W., Cannella B., Mazzaccaro R.J., Clements J.M., Miller K.M., Wucherpfennig K.W., Gearing A.J., Raine C.S. Effective treatment of models of multiple sclerosis by matrix metalloproteinase inhibitors. Ann. Neurol. 44:1998;35-46.
6. Mantovani G., Maccio A., Madeddu C., Mura L., Gramignano G., Lusso M.R., Murgia V., Camboni P., Ferreli L., Mocci M., Massa E. The impact of different antioxidant agents alone or in combination on reactive oxygen species, antioxidant enzymes and cytokines in a series of advanced cancer patients at different sites: correlation with disease progression. Free Radic. Res. 37:2003;213-223.
7. Marracci G.H., Jones R.E., McKeon G.P., Bourdette D.N. Alpha lipoic acid inhibits T cell migration into the spinal cord and suppresses and treats experimental autoimmune encephalomyelitis. J. Neuroimmunol. 131:2002;104-114.
8. Nagamatsu M., Nickander K.K., Schmelzer J.D., Raya A., Wittrock D.A., Tritschler H., Low P.A. Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy. Diabetes Care. 18:1995;1160-1167.
9. Packer L., Tritschler H.J., Wessel K. Neuroprotection by the metabolic antioxidant alpha-lipoic acid. Free Radic. Biol. Med. 22:1997;359-378.
10. Pluchino S., Quattrini A., Brambilla E., Gritti A., Salani G., Dina G., Galli R., Del Carro U., Amadio S., Bergami A., Furlan R., Comi G., Vescovi A.L., Martino G. Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis. Nature. 422:2003;688-694.
11. Raine C.S., Cannella B., Hauser S.L., Genain C.P. Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: a case for antigen-specific antibody mediation. Ann. Neurol. 46:1999;144-160.
12. Selmaj K., Cross A.H., Farooq M., Brosnan C.F., Raine C.S. Non-specific oligodendrocyte cytotoxicity mediated by soluble products of activated T cell lines. J. Neuroimmunol. 35:1991;261-271.
13. Sen C.K., Packer L. Antioxidant and redox regulation of gene transcription. FASEB J. 10:1996;709-720.
14. Smith K.J., Kapoor R., Felts P.A. Demyelination: the role of reactive oxygen and nitrogen species. Brain Pathol. 9:1999;69-92.
15. Smith K.J., Kapoor R., Hall S.M., Davies M. Electrically active axons degenerate when exposed to nitric oxide. Ann. Neurol. 49:2001;470-476.
16. Steinman L. Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell. 85:1996;299-302.
17. Suzuki Y.J., Aggarwal B.B., Packer L. Alpha-lipoic acid is a potent inhibitor of NF-kappa B activation in human T cells. Biochem. Biophys. Res. Commun. 189:1992;1709-1715.
18. Teichert J., Hermann R., Ruus P., Preiss R. Plasma kinetics, metabolism, and urinary excretion of alpha-lipoic acid following oral administration in healthy volunteers. J. Clin. Pharmacol. 43:2003;1257-1267.
19. van der Goes A., Brouwer J., Hoekstra K., Roos D., van den Berg T.K., Dijkstra C.D. Reactive oxygen species are required for the phagocytosis of myelin by macrophages. J. Neuroimmunol. 92:1998;67-75.
20. Willenborg D.O., Staykova M.A., Cowden W.B. Our shifting understanding of the role of nitric oxide in autoimmune encephalomyelitis: a review. J. Neuroimmunol. 100:1999;21-35.
21. Wolf K., Mazo I., Leung H., Engelke K., von Andrian U.H., Deryugina E.I., Strongin A.Y., Brocker E.B., Friedl P. Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis. J. Cell Biol. 160:2003;267-277.
22. Zhang W.J., Frei B. {alpha}-Lipoic acid inhibits TNF-{alpha}-induced NF-{kappa}B activation and adhesion molecule expression in human aortic endothelial cells. FASEB J. 15:2001;2423-2432.
23. Ziegler D., Hanefeld M., Ruhnau K.J., Meissner H.P., Lobisch M., Schutte K., Gries F.A. Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study). Diabetologia. 38:1995;1425-1433.